FDA warns against off-label use of ketoconazole oral tablets

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-016-18059-9
中图分类号
学科分类号
摘要
引用
收藏
页码:3 / 3
相关论文
共 50 条
  • [41] Off-label use in neurology
    Diener, HC
    AKTUELLE NEUROLOGIE, 2002, 29 (08) : 379 - 381
  • [42] A Hemorrhage of Off-Label Use
    Avorn, Jerry
    Kesselheim, Aaron
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (08) : 566 - 567
  • [43] QUETIAPINE OFF-LABEL USE
    Levin, R.
    Cosmatos, I
    Dieck, G.
    Reifsnyder, J.
    VALUE IN HEALTH, 2016, 19 (07) : A522 - A522
  • [44] Off-label use of vaccines
    Neels, Pieter
    Southern, James
    Abramson, Jon
    Duclos, Philippe
    Hombach, Joachim
    Marti, Melanie
    Fitzgerald-Husek, Alanna
    Fournier-Caruana, Jacqueline
    Hanquet, Germaine
    VACCINE, 2017, 35 (18) : 2329 - 2337
  • [45] Off-label use of infliximab
    Onder, M.
    Salavastru, C.
    Fritz, K.
    HAUTARZT, 2013, 64 (10): : 757 - 761
  • [46] Off-Label Use vs Off-Label Marketing of Drugs Part 1: Off-Label Use-Patient Harms and Prescriber Responsibilities
    Van Norman, Gail A.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2023, 8 (02): : 224 - 233
  • [47] FDA publishes final rule on off-label information
    Barlas, S
    ONCOLOGY-NEW YORK, 1999, 13 (02): : 150 - 150
  • [48] From off-label prescribing towards a new FDA
    Tabarrok, Alex
    MEDICAL HYPOTHESES, 2009, 72 (01) : 11 - 13
  • [49] ‘Off-label’ drug use: an FDA regulatory term, not a negative implication of its medical use
    W A Meadows
    B D Hollowell
    International Journal of Impotence Research, 2008, 20 : 135 - 144
  • [50] 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use
    Meadows, W. A.
    Hollowell, B. D.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2008, 20 (02) : 135 - 144